The BioGenysis Corporation

BioGenysis is a seed-stage biopharmaceutical company that intends to design, develop, and market new antiviral therapeutic agents.
Our primary goal is to use genetic engineering and recombinant DNA technologies to produce novel therapeutics that will be effective in eliminating the deadly human immunodeficiency virus type 1 (HIV-1), the virus that causes the fatal immune system disease, acquired immunodeficiency syndrome (AIDS).

Activity:

- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

- AIDS
- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: